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Abstract Interactive voice response (IVR) is increasingly
used to monitor and promote medication adherence. In
2014, we evaluated patient acceptability toward IVR as
part of the ENRICH Study, aimed to enhance adherence to
isoniazid preventive therapy for tuberculosis prevention
among HIV-positive adults in Ethiopia. Qualitative inter-
views were completed with 30 participants exposed to
2867 IVR calls, of which 24 % were completely answered.
Individualized IVR options, treatment education, and time
and cost savings facilitated IVR utilization, whereas poor
IVR instruction, network and power malfunctions, one-way
communication with providers, and delayed clinic follow-
up inhibited utilization. IVR acceptability was complicated
by HIV confidentiality, mobile phone access and literacy,
and patient-provider trust. Incomplete calls likely reminded
patients to take medication but were less likely to capture
adherence or side effect data. Simple, automated systems
that deliver health messages and triage clinic visits appear
to be acceptable in this resource-limited setting.
Resumen La respuesta de voz interactiva (IVR por sus
siglas en ingle´s) se utiliza cada vez ma´s para monitorear y
promover el cumplimiento del medicamento. En 2014,
evaluamos la aceptacio´n del paciente a la respuesta de voz
interactiva (IVR) como parte del Estudio ENRICH, con el
objetivo de mejorar el cumplimiento de la terapia preven-
tiva de isoniacida para la prevencio´n de la tuberculosis
entre los adultos positivos al VIH en Etiopı´a. Las entre-
vistas cualitativas fueron completadas con 30 participantes
expuestos a llamadas 2867 IVR, de las cuales 24 % fueron
respondidas completamente. El acceso al tele´fono, las
opciones de la respuesta de voz interactiva (IVR), la edu-
cacio´n al tratamiento y el ahorro en tiempo y costo, faci-
litaron la utilizacio´n de la respuesta de voz interactiva
(IVR) del paciente, aunque la poca instruccio´n de la IVR,
el mal funcionamiento de la energı´a y de la red, la comu-
nicacio´n unidireccional con los proveedores y el segui-
miento clı´nico demorado, limitaron la utilizacio´n. La
aceptacio´n de la respuesta de voz interactiva (IVR) fue
complicada por la confidencialidad del VIH, el acceso al
tele´fono mo´vil y la alfabetizacio´n, ası´ como la confianza
proveedor-paciente. Las llamadas incompletas probable-
mente recordaron a los pacientes tomar el medicamento,
sin embargo, fue menos probable recoger los datos de
cumplimiento o de efectos secundarios. Los sistemas
simples y automatizados que transmiten los mensajes de
salud y las visitas de triaje a la clı´nica parecen ser acep-
tados en este entorno de recursos limitados.
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Despite the global scale-up of antiretroviral therapy (ART),
tuberculosis (TB) remains the leading opportunistic infec-
tion and cause of mortality among people living with HIV
(PLHIV), accounting for 26 % of HIV-related deaths
worldwide [1, 2]. In 2014, an estimated 1.2 million new TB
cases notified globally were HIV-coinfected; 74 % of these
were in Africa [3]. Ethiopia ranks tenth among high TB-
burden countries, with an estimated TB incidence of 207
per 100,000 [3]. Approximately 760,000 people were liv-
ing with HIV in Ethiopia in 2012 [4].
HIV infection greatly increases the risk of developing
TB, which may result from reactivation of latent TB
infection or rapid progression to disease after recent
infection [5]. Isoniazid preventive therapy (IPT) has been
shown to reduce TB incidence in PLHIV not on ART [6];
IPT also reduces TB incidence [6] and the risk of death in
patients on ART [7]. The World Health Organization
(WHO) strongly recommends that PLHIV receive at least
6 months of IPT as part of a comprehensive package of
HIV care, regardless of ART status [8]. Limited data from
high-burden, resource-limited countries, however, suggest
that adherence to IPT is suboptimal. In the WHO ProTEST
project, involving IPT provision after HIV counseling and
testing in Malawi, South Africa, and Zambia, only
24–59 % of patients completed the recommended course of
IPT [9]. In a more recent review of studies from Uganda,
South Africa, and Botswana, 47–88 % of patients com-
pleted IPT [10]; however, patients more likely to experi-
ence adherence challenges, such as those who were non-
adherent to therapies for other chronic conditions, had
experienced an adverse effect to IPT, and/or lived further
away from clinics, were excluded from studies reporting
higher rates [11–13]. There is an acute need to design and
evaluate interventions that effectively address IPT adher-
ence challenges so that the survival gains made with global
ART scale-up are not undermined by the devastating
impact of TB in PLHIV.
Mobile health (m-health), or the remote delivery of
health care via mobile phone communication is a promis-
ing means of supporting and monitoring adherence to
medication [14]. Mobile technology has the advantage of
covering rural populations with poor transportation
infrastructure in resource-limited settings [15]. The number
of mobile phone subscriptions in sub-Saharan Africa is
rising more rapidly than anywhere else in the world; the
increase from 89 million in 2005 to an estimated 635
million by the end of 2014 [16] allows for innovative use of
m-health technologies such as short-text messaging service
(SMS) and interactive voice response (IVR) to automate
health messaging and data collection.
The application of IVR to scientific research is becom-
ing increasingly popular [17]. IVR data collection combi-
nes computerized self-interviewing with touch-tone
telephone technology, allowing investigators to track par-
ticipants and gather data without direct interviewer contact
or deployment of complex, expensive equipment [17, 18].
Participants respond to automated questions by pushing
numbers on their telephone keypad; their responses,
recorded on a server connected to a phone network, may be
used in real time to target interventions to those who are
nonadherent [18]. IVR was recently tested as an interven-
tion tool to increase adherence to ART in Uganda, and
showed a high level of patient interest and participation
[18, 19]. An important advantage over SMS is that IVR
systems do not require participants to be literate. They are
particularly suited to patients in Ethiopia, where the adult
literacy rate is estimated to be 39 % [20].
As part of the ENhance Initiation and Retention in IPT
Care for HIV (ENRICH) Study, we employed IVR as a
tool to enhance adherence to IPT among adults living with
HIV in Ethiopia. This paper describes a qualitative evalu-
ation of patient acceptability toward IVR to inform its
implementation in our study setting.
Methods
For this evaluation, we used qualitative methods [21] to
explore patient experiences with IVR technology and
assess their acceptability toward IVR. The evaluation was
nested within the parent ENRICH Study (https://clin
icaltrials.gov NCT01926379), an implementation science
cluster-randomized trial aimed to evaluate the effectiveness
of a combination intervention package (CIP) versus stan-
dard of care, to improve initiation, adherence, and com-
pletion of a six-month course of IPT among HIV-positive
patients newly enrolled in HIV care at ten urban primary
health centers in Dire Dawa and Harari, Ethiopia. The CIP
was implemented at five of these health centers since July
2013. Among several programmatic, structural, and psy-
chosocial components, the ENRICH CIP incorporated real-
time adherence support, delivered to patients by IVR
technology in conjunction with a study-issued mobile
phone, SIM card, and airtime vouchers. The costs associ-
ated with provision of a mobile phone, SIM card and 6
months’ airtime to facilitate IVR calls were approximately
USD 45 per patient.
IVR System Specifications
Grameen Foundation (http://www.grameenfoundation.org)
developed the IVR system using an open-source MOTECH
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Suite application and managed the gateway for the IVR
system over the local phone network. Calls customized to
meet project needs and recorded by local radio personali-
ties in four indigenous languages were placed through the
Ethio Telecom mobile phone network (www.ethiotelecom.
et). Health care workers utilized a tablet application
developed by Commcare (http://www.commcarehq.org) to
register patients’ phones to receive calls according to
specified timing; this information was transmitted to
MOTECH via the 2G cellular network.
IVR Call Algorithm
The IVR system was designed to send four types of fully
automated messages: (1) medication reminders (sent daily,
and modifiable to weekly after the 1 month as per patient
preferences); (2) appointment reminders (sent 1 and 2 days
prior to monthly clinic visits); (3) adherence assessments
(sent monthly); and (4) side effects assessments (sent
monthly). To protect confidentiality, patients entered a self-
selected personal identification number (PIN) in order to
access and respond to any IVR message, until which time a
locally popular musical melody was played. Patients were
asked to key a response to all IVR messages. All IVR calls
ended by thanking patients and asking if they had questions
or concerns or wanted to be contacted by clinic staff. Patients
who requested speaking with clinic staff were contacted by
phone within 24 h. IVR calls that went unanswered were
automatically re-sent 30 min later after which the call was
recorded as incomplete (i.e., no answer). The IVR system
generated lists of patients who did not respond to the auto-
mated messages, experienced PIN failures, reported non-
adherence or side effects, or ask to be contacted, based on
their keyed responses (see Figs. 1, 2 for illustrative examples
of the IVR call algorithms). Patients could use the phone for
personal use and to call their clinic to speak directly with
clinic staff; they could also use the study SIM card and air-
time with their own phone. Study staff trained patients on
mobile phone use, PIN selection, and IVR call algorithms,
with opportunity to practice receiving and responding to
messages; patients were also counseled to take daily doses
regardless of whether calls were received, in anticipation of
missed calls and power or network outages. Patients chose
from four available languages and selected a time to receive
IVR calls, all of which were modifiable. Training was
repeated a week after IPT initiation, and as needed.
Qualitative Data Collection
Data for the qualitative evaluation were collected from May
to June 2014 via interviews with 30 patient participants
enrolled in the parent ENRICH Study who were enrolled at a
CIP site and receiving intervention-based adherence support
for IPT for a minimum of 2 weeks. We used heterogeneous
sampling [21, 22] to recruit a diverse sample of patient
participants, based on their gender, age, study site, and
duration of exposure to IVR and IPT, to capture a broad
range of issues that could influence acceptability toward
IVR. The interviews were audio-recorded and privately
conducted in Amharic, the most commonly spoken language,
by a trained qualitative interviewer. Open-ended, exploratory
questions were comprised within a semi-structured interview
guide [23], and asked in casual, non-judgmental, and cul-
turally sensitive ways to facilitate capture of participants’
perceptions and attitudes toward IVR, and perceived benefits
and challenges to using IVR technology within their partic-
ular social contexts. The sequence and wording of questions
changed with each interview based on participants’ indi-
vidual responses to yield greater insight into their unique
experiences.
Compliance with Ethical Standards
The parent ENRICH Study and nested qualitative study
received human subjects approval from the Columbia
University Medical Center Institutional Review Board (Ref
IRB-AAAK3163) and the National Research Ethics Review
Committee in Ethiopia (Ref 3.10/780/06). All participants
provided written, informed consent to participate in the
parent ENRICH Study at the time of enrollment, and be
interviewed monthly during IPT. As qualitative interviews
were conducted with a smaller group of ENRICH partici-
pants, adjacent to a routine ENRICH Study interview,
additional verbal, informed consent was sought and obtained
for the qualitative interview. Verbal, informed consent was
facilitated by providing participants with a detailed
description of the qualitative study in print, in Amharic and
read out in full by the interviewer. Participants were given
adequate opportunity to ask questions about the qualitative
study, and the voluntary nature of their participation was
emphasized. Participants were also informed that their par-
ticipation or refusal to participate in the qualitative study
would have no impact on the type or quality of care they
received under the ENRICH Study, and/or at their clinic.
Verbal consent was recorded by the interviewer on distinct
interview sheets, prior to commencement of each qualitative
interview. All participants approached for the qualitative
interview agreed to participate. They were each provided
with a light snack and soft drink. The study adhered to
COREQ guidelines [24].
Analysis
Audio recordings from the interviews were transcribed
verbatim, translated, anonymized, and thematically analyzed
using a grounded theory framework [21, 25]. Transcripts
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were coded independently by two study investigators, who
practiced critical reflexivity and crosschecked emerging
codes in consultation with the interviewer to enhance inter-
rater reliability and ensure that the analysis was grounded in
participants’ narratives [25]. Codes were further refined and
contextualized through a process of constant and discursive
comparative analysis [25] to facilitate the emergence of
several intersecting themes, described ahead. Data inter-
pretations were also informed by existing understandings of
patient experiences, decision-making, and m-health inter-
ventions in TB and HIV. Qualitative analysis was supple-
mented by the following data: participants’ socio-
demographic characteristics at baseline, collected via inter-
viewer-administered standardized questionnaires at the time
of enrollment into the parent study; and their aggregate IVR
usage, collected via weekly IVR logs produced by
MOTECH from baseline to the point of qualitative
interview.
Findings
Interviews were completed with 16 women and 14 men
(Table 1). At baseline, participants’ mean age was 33 years
(range 18–58 years). The average household size was 3.2,
and 50 % of participants were married or living together
with their partner. Sixty-seven percent were working, 93 %
reported having electricity in the household, 50 % reported
a telephone in the household, and 50 % reported owning a
cell phone. Seventy-three percent of participants had
completed primary school. Literacy, defined as the ability
to read a whole sentence, was reported by 57 % of par-
ticipants. Seventeen percent of participants had not dis-
closed their HIV status to anyone outside of the health
system.
Participants were proportionately distributed across the
study intervention sites. At the time of interview, they had
been on IPT and exposed to the IVR system for an average
of 17.4 weeks (range 4–26). Of 2867 calls attempted for
the 30 participants, 90 % were daily medication reminder
calls, 6 % were monthly appointment reminder calls, 2 %
were monthly adherence assessment calls, and 2 % were
monthly side effects assessment calls. IVR calls were
completely answered, with PIN entry and response to the
automated message, 24 % of the time. The most common
reasons that calls were designated incomplete were: no
answer (48 %), premature disconnection by the network or
participant (25 %), and PIN failure (14 %) (Table 1).
Four themes emerged from our data: satisfaction with
automated calls, maintaining HIV confidentiality,
Fig. 1 Example of IVR flow




preferences for calls versus visits, and literacy related to
IVR technology.
Satisfaction with Automated Calls
Overall, participants were enthusiastic about the IVR
component of the CIP. Fifteen participants had not owned a
phone, and for most of them, this was their first time
interacting with mobile technology. They were grateful to
have been entrusted with a device that would have other-
wise remained inaccessible to them.
The various messages offered many participants a sense
of ‘‘life’’ or ‘‘health’’. Daily reminders relieved participants
of the stress of having to remember to take their medication
every day, and delivered a novel form of treatment support
that many were unable to receive in their home or from
relatives.
‘‘What I would like and love from the phone device,
it reminds me. It reminds the time when I am taking
my medication and helping me not to be reluctant… I
think the phone is given to me as a guarantee to my
life… When I see that I am becoming well, as
Fig. 2 Example of IVR flow chart for medication adherence assessment call
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compared with the one I suffered, I would like to
thank them… the one which is being done is secretly
and nobody knows about me… When I take my pills
at this time, who supported me? My families, my
brothers do not support me.’’ 40 y.o. male
Several participants believed they would have forgotten
or delayed taking their medication had it not been for the
automated calls. They reported being more aware of the
importance of timely treatment intake as a result of the
daily reminders, and this appeared to boost their commit-
ment to IPT. In many instances, the call itself was con-
sidered an adequate reminder even when participants did
not proceed to answer the call, enter their PIN, and/or
respond completely to specific messages.
‘‘Since I can easily forget, it helps to remind me…
Because of work related and as a human being, I
forget. When I receive a call, I remember and take it
immediately.’’ 27 y.o. female
‘‘When the phone rings, I know that it is eight
o’clock. Even if I forget taking my pills, while put-
ting my phone [in my pocket] or somewhere in the
house, when I listen to the ring, I will say it is eight
o’clock and take my pills.’’ 25 y.o. female
Most participants said they had successfully integrated
the IVR calls into their daily routines. They had self-se-
lected preferred times for IVR calls (six participants opted
to receive weekly, as opposed to daily medication remin-
ders after 1 month of IPT), and many reported carrying the
mobile phone on their person to avoid missing an IVR or
related call from their clinic. Participants enjoyed that calls
began with a musical melody that mandated PIN entry
Table 1 Baseline participant characteristics and summary of IVR
calls information
n = 30 N (%)
Age, y





On ART 28 (93 %)
Unknown 2 (7 %)
Marital status
Married/living together 15 (50.0)
Divorced/separated 7 (23.3)
Widowed 4 (13.3)
Never married/never lived together 4 (13.3)
Number of household members
Mean (SD) 3.2 (2.2)
Education level
No school 2 (6.7)
Primary school 20 (66.7)
Secondary school 6 (20.0)
Higher 2 (6.7)
Employment
Working for cash/in-kind payment 19 (63.3)
Not working for payment 1 (3.3)
Not working at all 10 (33.3)
Electricity in household 28 (93.3)
Telephone in household 15 (50.0)
Owns a cell phone 15 (50.0)
Literacy
Cannot read at all 7 (23.3)
Only able to read part of sentence 6 (20.0)
Able to read whole sentence 17 (56.7)





Disclosed HIV status toa




Pill reminder 2591 (90.4)
Appointment reminder 168 (5.9)
Adherence assessment 53 (1.9)
Side effects assessment 55 (1.9)
Table 1 continued





Reasons for incomplete calls
No answer 1056 (48)
Failedb 540 (24.6)
PIN failure 304 (13.9)
Busy 76 (3.5)
Unknown 217 (10)
a Multiple answers allowed
b Failed calls included those that were disconnected prematurely
(before IVR messages were completely played) either by the partic-
ipant or due to a network malfunction
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before any personal health or treatment related messages
were played. Participants appreciated that PIN entry helped
protect their ‘‘secrets’’ or the confidentiality of their illness.
‘‘When they gave me the phone device. It has a code
and nobody can pick the received call and I correctly
insert the code… for example if I put my phone
device and go away, anybody cannot know my
secrets.’’ 30 y.o. male
Maintaining HIV Confidentiality
It followed that while participants appreciated receiving a
phone as part of the study intervention, it became a marker
of their illness, and only a few discussed it with relatives
and friends. Most participants were reticent about dis-
closing its purpose to others, as they were afraid it could
lead to HIV disclosure.
‘‘My friends ask me and tell them that I bought it by
myself. However, I don’t tell them that I got it from
here because my friends don’t know about my ill-
ness… it is a secret.’’ 29 y.o. male
All participants accepted the study-issued phone. How-
ever, some participants who owned a phone prior to the study
reported transferring the study SIM card into their existing
device to avoid arousing suspicion about a new phone.
‘‘My relative always asks me where I got the phone
and I wanted to hide from her. She is talkative. I
inserted the SIM into this phone device and hide that
device in my house… it is to limit the spread of
rumors.’’ 50 y.o. female
When answering IVR calls, participants adopted diverse
strategies to avoid drawing attention to themselves. They
found a reason to be excused when in the company of
people to whom they had not disclosed. Several partici-
pants altogether rejected IVR calls when in public.
‘‘Every day when the call comes, I know that it is
from them; even if I am with somebody, I will walk
away.’’ 25 y.o. female
‘‘Sometimes when somebody sat beside me, or peo-
ple around me, I was scared to respond the call, and
reject the call.’’ 23 y.o. female
At least one participant kept her phone hidden and
disconnected except when she expected the IVR call. She
had not disclosed her HIV status to her partner, with whom
she lived, and was afraid of his reaction if he were to
discover the purpose of the phone or the automated calls.
Consequently, she did not respond to follow-up calls that
were made outside of this specified time.
Alongside privacy concerns, participants commonly
turned off their phones in order to save battery power in
anticipation of power outages. Participants who said they
rejected IVR calls due to a lack of privacy, or left their
phone turned off or away from their person for extended
periods, more often reported not receiving IVR calls
consistently.
Preferences for Calls Versus Visits
Participants had varying responses in relation to their
preferences for IVR calls and in-person clinic visits. Most
participants appreciated the convenience of discussing their
health status over the phone, and triaging symptoms in
advance of enduring the cost and time associated with an
in-person visit.
‘‘It is better to communicate via phone. Rather than
coming from my house to here; transportation prob-
lem and lots of suffering while travelling.’’ 23 y.o.
female
The ability to communicate via phone alleviated some
participants’ stress of speaking directly to clinic staff or
being identified by others at an HIV clinic, and having to
deal with the social criticism, judgment or stigma related to
such events.
‘‘When responding via phone, nobody watches and
gazes at me so the phone benefits me in this… I mean
since I can get information how to use the pill while
staying at home, I am not expected to come and ask
the doctor how is this, what is that.’’ 35 y.o. male
‘‘I can explain very well via phone device and you
don’t know who I am and you only know my number.
So I can talk with my problems without any fear. If it
was in physical presence, it could be difficult and I
am scared to talk, so I think it has this advantage.’’ 58
y.o. male
Participants also appreciated that the phone strengthened
their capacity to communicate directly with clinic staff, of
their own volition, rather than waiting to voice their con-
cern at a scheduled visit.
‘‘The phone is very important because it helps me to
call and communicate with them when I am sick and
receive calls from the clinic. Rather than totally
depend on somebody, I can receive calls and I am
able to call them when appropriate.’’ 55 y.o. female
It became clear over the course of the study that it was this
capacity to speak with a health care worker, as opposed to
communicate with an automated system, that drove partici-
pants’ preference towards phone-base communication.
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‘‘If I encounter side effects, for example tingling or
numbness, itching, nausea I have already told her, I
will rather communicate via her personal phone
rather than waiting for all these numbers and
respond.’’ 40 y.o. male
A smaller group of participants were explicit in their
preference to interact with health care workers in person.
They believed a clinic visit was the only way to have their
problems appropriately addressed.
‘‘It is better to go and talk to nurses than via phone.
Responding via phone is good but it is better to come
here and show my body. For me, it is better to speak
and say I encountered this. Over the phone, I only
follow the computer instruction, I cannot talk.’’ 38
y.o. male
Most of these participants expressed greater difficulty
understanding and responding to the automated messages.
They also appeared to suffer more social hardships and
need a greater degree of health care worker support,
compared to participants who voiced more positive expe-
riences with the IVR system.
‘‘There is a need of psychological morale for patients.
Sometimes, as life become difficult, people lose their
hope so there should be somebody to encourage
them… they have to give priority to those physically
weak and very sick patients.’’ 40 y.o. male
Literacy Related to IVR Technology
The wide variation in participants’ literacy and under-
standing related to IVR technology became apparent as
their responses to specific IVR messages were probed.
Although they all reported being satisfied with the
instruction offered on the use of the mobile phone and IVR
system, very few participants demonstrated a clear under-
standing of the four types of IVR messages and expected
responses. Participants said they failed to enter their PIN
within the stated timeframe, key appropriate entries that
were meant to confirm medication adherence or record
experiences with side effects, and sometimes forgot their
PIN. A few participants found the IVR messages to be
brief, with insufficient explanation on possible responses.
This was corroborated by the high proportion of IVR calls
designated incomplete.
‘‘Some of the messages might not be clear to
understand… It is because when they said, ‘If you
have problem press one, if not press three’, it is very
short and how many people could understand this?’’
58 y.o. male
‘‘When I receive the call, I pick up the phone. I listen
to, I don’t say hello but simply put the phone on my
ear. After I see the classical [music] then I end the
call… but I don’t know about the code.’’ 45 y.o.
female
However, despite poor IVR literacy, participants
appeared to be successfully reminded about their daily
doses. ‘‘The message is the music’’—that the phone rung at
a consistent time and played music each day was sufficient
reminder.
‘‘I listen to the music for a couple of minutes. I hear
no sound at all. It happens again and again. When the
time is 8:05 or 8:06 it ends by itself… I see my watch
and find out that it is the time to take my pills. In this
case, I prepare myself to take my pills… The main
thing is the time reminder.’’ 32 y.o. female
An important feature of the automated system allowed
patients to request a call-back from their clinic, and have
their concerns addressed over the phone in advance of
scheduled visits. This emerged as the most confusing
component of the IVR system, as participants who acti-
vated this feature expected to be immediately connected to
a health care worker.
‘‘When it says, ‘Press one’, when you press one, I
believe, it is better to have doctors to consult…
Sometimes there is a time which makes me very
uncomfortable… at which time I needed a doctor and
press number one but it ends the call.’’ 27 y.o. male
Participants’ confusion with this component of the IVR
system was compounded when staff failed to follow-up
call-back requests in a timely manner.
‘‘One thing I have reservation is it says ‘If you have
any questions, please press one to call to our clinic’.
Then when you press one, we receive an answer,
‘You will receive a call from the clinic immediately’.
However, I didn’t receive call… If I receive calls
when I press one it could be very good.’’ 40 y.o. male
Upon experiencing difficulties with the IVR system,
participants felt disinclined to have a relative or friend
examine the device or listen in on calls. They did not seek
clarification or retraining from clinic staff, worried that this
would be an imposition on staff time. Instead, they attrib-
uted any problem with the IVR system to a network mal-
function, even when it may have been due to clinic
oversight or personal error.
Participants dealt with these challenges by visiting their
clinic in advance of their scheduled appointment, for
immediate staff attention. A few participants turned off
their phones for a few days waiting for network problems
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to resolve. In general, though, they reported continuing to
take their daily doses on time, and adhering to clinic
appointments.
‘‘I call [the nurse] and tell her that I didn’t receive
calls from the clinic. She told me that it was the
network. Sometimes 30 min is passed from the usual
time and I said what happened to them… I do not
forget, they ordered me with precautions not to dis-
continue the pills. Then, I by myself remember cor-
rectly besides the telephone reminder.’’ 30 y.o. male
Discussion
To our knowledge, this is the first study to characterize
HIV-positive patients’ acceptability toward IVR technol-
ogy while receiving IPT, and to actively explore patient
preferences for phone-based and in-person communication.
Patients were exposed to IVR for up to 6 months, akin to
patients in other studies testing the effectiveness of IVR
[18, 26]. We identified several enablers to IVR use: indi-
vidualized IVR call times and frequency; treatment
understanding and awareness; and diminished costs and
waiting times related to clinic visits. We also identified
several barriers: inadequate instruction on phone and IVR
use; lack of clarity on various IVR messages and prompts,
including PIN entry; network malfunctions and possible
power outages; lack of two-way communication between
patients and providers; and delayed follow-up of automated
entries on the part of health care workers. Similar problems
with IVR comprehension, especially PIN entry, and a
failure to implement repeated interpersonal communication
have been identified as barriers to implementing phone-
based interventions among TB patients in India [26] and
PLHIV in Uganda [18].
We found provider trust and communication, HIV
stigma and confidentiality, phone and IVR literacy, and the
incentive of a new phone confounded IVR acceptability.
Several participants expressed dissatisfaction with the IVR
system because they were unable to directly communicate
with a trusted provider. However, participants who were
more familiar with mobile phones were empowered to
place direct calls to providers when needed, which
enhanced their acceptability toward IVR. Phone-based
communication also influenced participants’ visibility
within community and clinic settings in contrasting ways.
For many patients, IVR calls enabled release from the
stigma of being seen, labeled, and judged at an HIV clinic.
On the other hand, a new device as well as IVR calls
attracted unwanted attention upon patients who had not
disclosed their HIV status to household members. Finally,
access to a new phone—a perceived valuable
commodity—enabled acceptability among patients who
had not previously owned a phone. However, inexperi-
enced phone users were also more easily frustrated by their
attempts to manage automated calls. The complex ways in
which IVR acceptability could be enhanced or inhibited by
patients’ social and medical contexts should be considered
when deploying m-health innovations among HIV-affected
populations in similar high-burden settings (Fig. 3).
Among HIV-positive patients, IVR technology has pri-
marily been used to monitor and measure changes in health
behavior such as adherence to treatment [17, 18]. In our
study, most IVR calls were intended to encourage rather
than assess adherence to treatment. Although many of these
calls were designated incomplete under the algorithm’s
objective criteria, they likely served their purpose in
reminding patients to take medication. Incomplete calls,
however, may have failed to capture data on adherence to
treatment or frequency of side effects. We thus suggest that
the IVR system may be best suited as an adherence cue for
treatment intake and clinic visits, and as a tool to enhance
patient-provider communication, rather than to achieve




more complex tasks such as monitoring the frequency and
type of medication side effects. Research from Uganda has
similarly found that while IVR is acceptable to patients, it
is not an effective tool to assess adherence [19].
Our qualitative evaluation has some limitations. First,
the purposive sample allowed us to illustrate the diversity
in participant experiences with IVR. However, they may
not represent the perspectives of PLHIV in settings with
disparate levels of mobile phone utilization. In Ethiopia as
a whole, mobile phone coverage is lower than in our
sample, at 25 % [27]; acceptability may be exaggerated
when patients are incentivized by access to a novel,
otherwise inaccessible device. Elsewhere in Africa, mobile
phone usage is relatively higher, at 70 % [27]; improved
network coverage, proficiency with phone technology, and
lower perceived visibility related to phone use may col-
lectively lead to greater IVR acceptability in those settings.
Second, we interviewed participants at single points in
time, and at varying stages of IPT, which precluded an
understanding of changes in IVR usage over time. Longi-
tudinal analyses may allow us to gauge IVR acceptability
over longer periods, and its applicability in chronic con-
ditions. We may comprehensively analyze the IVR log data
once the ENRICH Study concludes, and participants
complete the full course of IPT. Third, oin an effort to
mitigate bias within the broader study analyses, we did not
link participants’ responses to their individual IVR logs.
Disaggregated data on IVR usage and objective measures
of adherence to IPT would have allowed us to validate the
subjective themes presented. We hope to achieve this once
the parent ENRICH Study concludes.
The study unveils important considerations for the
application of mobile phone technology in high HIV-bur-
den, resource-limited settings. First, patients receiving drug
therapy for extended periods may be highly motivated to
use IVR for treatment follow-up and support. The success
of such technology rests in its ability to adapt to patients’
complex and dynamic social environments through pro-
tection of their privacy, most notably in the case of HIV,
and flexibility in call algorithms. Second, simpler auto-
mated systems are more likely to have a sustained impact
on patient behavior, given their multiple social constraints,
structural deficiencies that compromise stable access to
phones and cellular networks, and a general lack of
familiarity with automated phone technology—though this
is likely to change as we have seen in other resource-lim-
ited areas in Asia and Africa. The scalability of IVR
interventions is also conceivable with rising cell phone
ownership, and with time, individual cell phone provision
may no longer be necessary. A majority of participants had
electricity in their homes, but concerns about potential
power outages were common, leading them to minimize
phone use to conserve battery power. This likely reflects
how patients may behave in other resource-limited settings.
While ongoing costs for IVR programming may be rela-
tively low, initial set-up costs are substantial. The findings
thus urge us to consider the utility of more cost-effective
tools such as missed calls (‘buzzing’ [28]) or SMS text-
messaging, with emoticons in case of low literacy, given
that incomplete IVR calls were considered adequate
adherence cues by many participants. Third, despite the
benefits of IVR-based communication and treatment
monitoring, it is not surprising that patients experiencing
side effects may be less satisfied with IVR and continue to
endure practical inconveniences to be seen by a health care
worker in person. Phone technologies in health may thus be
applied to triage the timeliness and frequency of such
visits, as opposed to replacing them altogether. They are
also more likely to be acceptable to patients who are in
stable health, familiar with mobile phone technology, and
more comfortable or open about their disease status.
Conclusion
This qualitative evaluation highlights important enablers
and barriers to IVR implementation from the perspective of
HIV-positive patients in Ethiopia. The complexity of these
determinants offers a gateway for future examination of the
suitability and feasibility of m-health innovations in
resource-limited settings. The findings were used to
enhance intervention delivery at the study sites. Staff were
trained to administer more interactive and user-friendly
IVR refresher training sessions for patients placed on IPT,
track and respond to patients’ requests for call-backs in a
timely manner, show greater empathy and sensitivity
toward patients who encountered difficulties with
responding to automated messages, and counsel patients on
innovative and tailored strategies to manage HIV disclo-
sure and confidentiality within the contexts of their social
realities. It is critical that we adopt such integrated
approaches to knowledge production in the field of
implementation science, and translate the lessons learned
to guide delivery of health care services.
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